General Information of the Compound
Compound ID
CP0519600
Compound Name
2-(1H-benzimidazol-2-ylmethyl)-5-phenyl-1,3,4-oxadiazole
    Show/Hide
Structure
Formula
C16H12N4O
Molecular Weight
276.299
Canonical SMILES
C(c1nc2ccccc2[nH]1)c1nnc(o1)-c1ccccc1
    Show/Hide
InChI
InChI=1S/C16H12N4O/c1-2-6-11(7-3-1)16-20-19-15(21-16)10-14-17-12-8-4-5-9-13(12)18-14/h1-9H,10H2,(H,17,18)
    Show/Hide
InChIKey
HDKMMBRKVCIVNF-UHFFFAOYSA-N
Physicochemical Property
logP
3.2037
Rotatable Bonds
3
Heavy Atom Count
21
Polar Areas
67.6
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 14738184
ChEMBL ID
CHEMBL4068254
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01233, Receptor tyrosine-protein kinase erbB-2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000083 MCF-7 Homo sapiens (Human)  1
1
IC50 = 40000 nM
   TI
   LI
   LO
   TS